In addition, fetuin-A has been shown to promote cytokine expression and low-grade inflammation by activating several pathways potentially involved in the development of NAFLD/MASLD, insulin resistance, beta cell apoptosis, and T2D. The gene discussed is AHSG; the disease is Insulin resistance.